Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board

Douglas P. Zipes MD Editor-in-Chief

See All Experts

featured

Published in Cardiology

Journal Scan / Research · May 28, 2015

Baroreflex Activation Therapy Effective for the Treatment of Heart Failure

JACC: Heart Failure

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Douglas Mann MD

JACC: Heart Failure

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction

JACC Heart Fail 2015 Apr 28;[EPub Ahead of Print], WT Abraham, MR Zile, FA Weaver, C Butter, A Ducharme, M Halbach, D Klug, EG Lovett, J Müller-Ehmsen, JE Schafer, M Senni, V Swarup, R Wachter, WC Little

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Baroreflex Activation Therapy Effective for the Treatment of Heart Failure

Additional Info

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction

Further Reading

Prognostic Implications of Clinical and Imaging Diagnostic Criteria for Myocarditis

Association Between Delay to First Shock and Successful First-Shock Ventricular Fibrillation Termination in Patients With Witnessed Out-of-Hospital Cardiac Arrest

Comparison of Drug Routes in Out-of-Hospital Cardiac Arrest

Transcatheter Valve Replacement in Severe Tricuspid Regurgitation

Unidirectional Association of Clonal Hematopoiesis With Atherosclerosis Development

TAVR in Patients With Asymptomatic Severe Aortic Stenosis

Prehospital Pulse-Dose Glucocorticoid in Patients With ST-Segment Elevation Myocardial Infarction

The Burden of Diabetes-Associated Multiple Long-Term Conditions on Years of Life Spent and Lost

TAVR in Younger Patients With Severe Aortic Stenosis at Low Surgical Risk: 3-Year Outcomes

Cardiovascular Events Following COVID-19 Vaccination in Adults

Conduction Disturbances and Outcomes After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis

Recently Updated